A novel prototype gel oscillator that functions by dissipating the chemical energy of glucose by an enzyme-mediated reaction is proposed. The product of the reaction modulates the degree of swelling and hence the permeability of a poly͑N-isopropylacrylamide-co-methacrylic acid͒ gel membrane which in turn regulates the flow of substrate to the enzyme. No external energy is required aside from the chemical energy of glucose present externally at constant concentration. A negative chemomechanical feedback loop is established which, coupled with hysteresis in the membrane permeability characteristics, produces pulsing oscillations. In this study, we introduce a simple model which provides guidelines for experimental design, and report preliminary experimental evidence for oscillation. Application of this prototype system to the episodic delivery of drugs and hormones is envisaged. © 1999 American Institute of Physics. ͓S1054-1500͑99͒00102-0͔
I. INTRODUCTION
The therapeutic efficacy of a drug depends on its intrinsic biological activity and its ability to be delivered to the site of action. In recent years the design and synthesis of new drugs has been facilitated by accumulated understanding of the structure and chemical properties of molecular targets, and by the arrival of synthetic techniques such as combinatorial chemistry. In addition, genetic engineering has provided tools for production of protein drugs which, just 20 years ago, were unavailable.
While the search for new drugs continues to be a major area of activity, drug delivery presents challenges to researchers who must find ways to overcome various physiological barriers, the nature of which depends on structural aspects of the drug molecule of interest. Particularly challenging has been the delivery of peptide and protein drugs, which are difficult to administer orally due to degradation in the gastrointestinal ͑GI͒ tract, and which are rapidly metabolized once in the bloodstream. 1 In other words, the bioavailability of such drugs tends to be diminished, and it is important to design drug delivery systems which address this problem. For example, polymeric implants containing proteins or other drugs can circumvent GI degradation, and also slowly and steadily release their payload into the circulation over long periods of time, obviating the need for repeated injections.
Layered upon issues of bioavailability is the importance of timing of drug delivery. While for most agents it is believed that a constant drug level is optimal, there are well known exceptions. For example, insulin is secreted by a normally functioning pancreas in order to maintain blood glucose at an approximately constant level, which would otherwise change during intermittent periods of food intake or during increased metabolic activity. Thus the normal pancreas can be regarded as a feedback controller, changing its output with time in accord with the need to maintain glucose homeostasis. Diabetes is a condition in which this capacity for regulating glucose levels is compromised, often by the failure of the pancreas to secrete sufficient insulin. Optimal treatment of diabetes should not only restore average insulin levels, but it should also reproduce the normal pancreas' feedback controlling function, 2 and an implant which deliv-ers constant levels of insulin will not succeed in its therapeutic objective. The failure of current insulin dosing regimens, including those involving injections, to properly mimic the function of a normal pancreas has been implicated in the development of the long term, degenerative conditions associated with diabetes. 3 Because of this failure there have been numerous attempts to construct implantable drug delivery systems whose insulin release rates are responsive to blood glucose concentration. [4] [5] [6] [7] [8] In recent decades evidence has accumulated that numerous hormones are endogenously released in a periodic, pulsatile manner. [9] [10] [11] Unlike insulin, whose release from the pancreas is triggered by an increase in blood glucose concentration, these hormones pulsate regularly in an apparently autonomous manner, with periods varying from tens of minutes to a day, depending on the hormone. While the physiologic basis and purpose of these pulsations is not well understood ͑although hypotheses have been generated 9, 10, 12 ͒, clinical studies have shown that in certain cases restoration of proper hormone function requires that not only the level, but the periodicity of exogenously administered hormone should mimic the endogenous pattern. For example, Southworth et al. 13 showed that pulsatile administration of gonadotropin releasing hormone ͑GnRH͒ every 90 min ͑the endogenous period͒ can restore menstrual and ovulatory function in women, whereas continuous delivery of GnRH at the same average rate fails to do so. Similarly, pulsatile administration of GnRH has been used successfully to induce sexual maturation in males suffering from delayed puberty. 14 As a third example, Brewitt and Clark 15 showed that cultured developing ocular lenses attain a transparent state when exposed to periodic ͑every 6 h͒ pulses of platelet derived growth factor ͑PDGF͒, but become cloudy when exposed to constant levels of PDGF. The intermittent delivery of epidermal growth factor ͑EGF͒ in corneal wound healing was studied by Sheardown and Cheng, 16 who found that this mode was preferable to constant rate infusion. Finally, evidence has been presented that calcitonin, an important hormone regulating calcium metabolism in bone, is more efficacious when administered once daily than when it is given continuously. 17 This observation may find importance in treating osteoporosis.
Besides hormones, other classes of drugs which may require pulsatile administration include those agents whose effect and or toxicity exhibit circadian rhythms, 18 drugs which exhibit tolerance, 19 and cell cycle-specific anticancer drugs. [20] [21] [22] While episodic delivery of implanted drugs might be achieved with the input of pulses of external energy ͑e.g., magnetism, 23 electricity, 24 ultrasound, 25 and light 26 ͒, we have been interested in developing a device that pulsates autonomously, using a constant endogenous chemical energy source. Blood glucose is readily available at approximately constant concentrations in nondiabetic individuals, and can serve as such a source. ͑Therefore this device would not be intended for insulin delivery to diabetics.͒ In this paper we describe a prototype scheme for a pulsating system, based on unstable negative feedback between the swelling and deswelling of a weakly acidic, hydrophobic polyelectrolyte gel, the transport of glucose through that gel, and enzymatic conversion of glucose to protons. The resulting fluctuations in pH and the ensuing rhythmic pulsing of the gel provide the basis for modulation of drug release.
Polyelectrolyte gels are crosslinked polymer networks which contain either permanently or reversibly charged side chains. [27] [28] [29] [30] [31] These networks can absorb water and swell, thus altering their ''mesh sizes'' and hence their permeability to molecules, depending on the molecular weight and charge of the permeant. 32 External factors affecting the degree of swelling are temperature, pH, and electrolyte composition. These factors act on the gel through three important forces: ͑1͒ the mixing tendency of water and the polymeric material, which includes pure configurational entropy and water/ polymer contact free energy terms. When the gel material is hydrophobic, this force favors gel collapse; ͑2͒ the entropic elasticity of the network; and ͑3͒ a force controled by the extent of ionization of the gel. The latter term may be interpreted either as electrostatic interaction among charged groups and between these groups and mobile electrolyte, or as a Donnan osmotic swelling pressure. All of these forces are nonlinear and, depending on the nature of the gel and its environment, the balance of forces may be such that a small change in an external parameter such as temperature or pH can cause a large change in gel swelling. It is also possible to create circumstances where multiple stationary swelling states exist, such that swelling can undergo discrete transitions in response to infinitesimal changes in the external parameter. 30, 33, 34 Multiple stationary swelling states in a gel suggest an analogy with chemical reactions that exhibit multiple steady states. Since many chemical oscillators are based on coupling of such reactions with a second ''feedback'' reaction which causes the chemical system to flip back and forth between steady state attraction domains, [35] [36] [37] [38] [39] it seems that oscillations in gel swelling and deswelling, with concomitant changes in permeability, should be possible by coupling swelling to a feedback process. In this paper we will argue that transport of glucose through the gel and enzymatic conversion of glucose to acidic protons provide the required feedback.
The paper is organized as follows. We first present a scheme for a gel/enzyme-based device, provide a minimal model for its function, and elicit criteria for pulsing, oscillatory behavior which should continue indefinitely. Second, we construct the prototype and present results of experiments demonstrating that the system can oscillate. However, the oscillations decay to an apparent steady state. Third, we attempt to explain the present failure to produce indefinite oscillations, and suggest approaches to overcome this failure. Finally, we contrast the present system with related systems that have appeared in the literature.
II. DEVICE DESIGN AND MODEL
The prototype device ͑Fig. 1͒ consists of a drugcontaining chamber that communicates with the external environment through a hydrogel membrane containing anionic comonomers. This membrane, consisting of poly͑N-isopropyl acrylamide-co-methacrylic acid͒ ͑NIPA/MAA͒, swells with increasing pH and collapses with decreasing pH. 40, 41 Inside the chamber is the enzyme glucose oxidase, which catalyzes the conversion of glucose to gluconic acid. 42 The latter dissociates (pKaϷ3.7 in 0.05 M NaCl͒ to gluconate and hydrogen ions:
The external environment is assumed to contain a constant concentration of glucose. Consider now an initial condition with the membrane in its swollen state where it is permeable to glucose and drug. External glucose diffuses into the device and is converted enzymatically to hydrogen ion which causes membrane collapse, with subsequent shutdown of glucose and drug permeation. Eventually, the hydrogen ion concentration depletes, leading to reswelling of the membrane and restored permeability to glucose and drug. This brings the device back to its initial state, and the process of membrane collapse and reswelling can repeat itself, indefinitely.
The functional dependence of the membrane's glucose permeability on proton concentration in the chamber ͑i.e., pH) is of major importance. In earlier work a sharp but monotonically decreasing relation between proton concentration and membrane permeability to glucose was assumed. 43, 44 It was shown that under this assumption, sustained oscillatory behavior can be achieved only under rather stringent conditions which will be difficult to maintain. Here we assume that membrane permeability to glucose shows hysteresis in its response to pH changes. Such hysteretic behavior was previously demonstrated for the NIPA/MAA hydrogels to be used in the present study. 33, 41 In order to generate a minimal model of the device, a few assumptions are made, the justifiability of which will be evaluated later:
͑1͒ The chamber is well stirred with constant concentration throughout. ͑2͒ The external environment is considered to be a well stirred source of glucose, with constant concentration G, and a perfect sink for protons. ͑3͒ Enzymatic conversion of glucose to protons in the chamber is extremely fast, such that conversion can be considered immediate upon appearance of a glucose molecule in the chamber. ͑4͒ The membrane's resistance to diffusion of protons can be characterized by a lumped permeability, of constant value P h . Binding of protons to the membrane, while controlling the membrane's permeation state, is assumed to be negligible when calculating proton mass balances. ͑5͒ The membrane's resistance to diffusion of glucose can be characterized by a lumped permeability coefficient, P g , which is a piecewise constant function of present hydrogen ion concentration in the chamber, with hysteresis, as illustrated in Fig. 2 . When the hydrogen ion concentration, denoted by h, is low, P g takes the value P gH , where H denotes ''high'' permeability. This state will persist until h increases past the critical value h HL , at which point glucose permeability drops immediately to the value P gL ϽP gH , where the subscript L denotes ''low'' permeability. The membrane will stay in the L state until h decreases past the value h LH , at which point the system returns immediately to the H state. Hysteresis requires that h LH Ͻh HL .
Under these assumptions the behavior the system is governed by a piecewise hysteretic, linear first order differential equation,
where A is the membrane area and V is the chamber volume: While it is easy to solve Eqs. ͑2͒ exactly given any initial condition, we are presently interested in conditions for oscillations, and the following analysis is more illuminating ͑see Fig. 3͒ past h HL and cause the membrane to flip to the L state. By similar argument, Eq. ͑2b͒ predicts that the system will flip back to H from L if h LH Ͼh SS,L ϭP gL G/P h . Combining these relations, we find that the system will oscillate indefinitely when
The prediction in Eq. ͑3͒ of upper and lower bounds on external glucose concentration is readily explained. When external substrate concentration is too low, proton concentration in the chamber never gets high enough to cause a flip to the L state. When external substrate concentration is too high, residual glucose permeability in the L state provides sufficient protons to keep the membrane collapsed, never to return to the H state.
When the assumptions of this simplified model hold, the system pulses regularly. Letting T H and T L be the ''pulse width'' ͑high permeability state͒ and the ''interpulse interval'' ͑low permeability state͒, respectively, it is readily shown that
A detailed analysis of a more general model, in which some of the assumptions are relaxed, has been published elsewhere. 45 
III. EXPERIMENTS A. Materials and methods
Crosslinked NIPA/MAA gel membranes were prepared as described elsewhere. 41, 46 Briefly, a mixture of 89 mol% NIPA ͑Kodak͒, 10 mol% MAA ͑Kodak͒, 1 mol% of the crosslinker tetraethylene glycol dimethacrylate ͑EGDMA Polysciences͒, and a small amount of the initiator 2,2Ј-Azobisisobutyronitrile ͑Kodak͒ was dissolved in 1-4 dioxane ͑Fisher͒ such that the dioxane mass was double the total monomer mass. This solution was injected between two glass plates separated by 0.5 mm Teflon gaskets, and polymerized at 60°C. The resulting membranes were conditioned in a series of methanol/water cosolvents and stored at 37°C in an aqueous 50 mM NaCl solution containing 3 mM sodium azide ͑a preservative: Aldrich͒.
The membranes were mounted between two chambers of a temperature controlled ͑37°C throughout the experiment͒ side-by-side diffusion cell, as illustrated in Fig. 4 . The cell consisted of a ''donor'' and a ''receptor'' chamber, each with fluid volume 75 ml. The aperture between the chambers permitting diffusion through the membrane had area 3.14 cm 2 . The receptor cell pH was set at pH 4.9-5.1 and the donor cell pH was set at 7.0. This pH gradient was maintained for 20 h. Glucose oxidase ͑Aspergillus Niger, type VII, 130 000 IU/g, also containing gluconolactonase and catalase: Sigma͒ was then added in the receptor cell ͑21 IU/ mL͒ and the system was allowed to sit for another hour.
At the beginning of a run the pH-stat of the receptor chamber was disconnected, and glucose was introduced in the donor cell. The pH of the receptor chamber was then monitored with time while the donor cell's pH was clamped at 7.0. Glucose concentration in the donor cell was maintained constant by continuously circulating a stock solution of glucose at a rate of 1 ml/min.
All solutions bathing the membrane after mounting in the test cell contained 50 mM NaCl and Bronopol ͑0.01% m/v͒, which was added as a preservative. Fig. 2 Figure 5 shows the results of a run in which glucose concentration in the donor cell was first set at 5 mM, which is within the normal physiologic range. The pH of the receptor cell decreased rapidly as a result of the enzymatic conversion of glucose to gluconic acid until it passed just below 4.7, where shutoff of the membrane to glucose occurred. Thereafter the pH increased slowly to a maximum (pH 5.08͒ and started to decrease again but at an even slower rate, suggesting approach to a steady state. About 48 h after the experiment began, glucose concentration in the donor cell was lowered to 2 mM. Following this the direction of the pH change was reversed immediately and another, sharper peak with a maximum of pH 5.15 was obtained, followed by convergence to a constant pH value of about 4.92. Figure 6 displays the results of a second run, in which the donor glucose concentration was set at 1.5 mM. This led to a sharp first peak in pH and a second, slower peak, but the system tended toward a steady state after 4 days. The receptor compartment was then spiked with 0.15 ml 0.01 N HCl, and held at pH 4.8 with a pH-stat burette that was withdrawn after 3 h. This drove the membrane back to its shutoff state, after which was observed another peak similar in shape to the first sharp peak, but again the system settled to a steady state pH.
FIG. 3. Temporal behavior of system illustrated in

B. Results
The pH downswings in Figs. 5 and 6 correspond to the high glucose permeability state, while the upswings occur when the membrane is shut down to glucose. During the down swings, the membrane tended to vibrate in response to the magnetic stirring, indicating a loose, swollen state. During the up swings, the membrane became more taut and vibrated much less, suggesting a collapsed state.
IV. DISCUSSION
In the theoretical section of this paper we introduced a model which requires that the gel membrane's permeability to glucose be inhibited by protons in a manner that exhibits hysteresis, and that the permeability to protons be essentially constant. Previous studies have established these properties for the NIPA/MMA membranes used in the present work. 33, 41, 46 Glucose permeability hysteresis was established by experiments using the same cell as in Fig. 4 , but where pH in the receptor chamber was varied in a controlled manner using a pH stat, keeping the donor pH at 7.0. 41 Flux of 14 C-labeled glucose from donor to receptor compartment was monitored as the receptor pH was changed in discrete steps ͑0.1 or 0.2 units͒. While results depended on precise membrane and solution conditions, typically it was found that when the experiment is started with receptor pHϭ5.3-5.4, and with pH stepped downward at hourly intervals, a steady flux of glucose is seen until pH passes through values between 4.9 and 4.7, at which point glucose flux becomes sharply attenuated. If pH is now increased in hourly steps, glucose permeation remains very low until pH increases past at least 5.1, at which point the original high glucose flux is restored. The difference in shutoff and restoration pH's does not depend on pH history, and that the membrane's hysteretic response can be repeated through several cycles. 41 Thus, we believe that the observed hysteresis is intrinsic to the membrane's swelling response and is not due to a dynamic lag.
Another previously reported experiment using the same side-by-side apparatus dealt with membrane permeability to glucose and protons in the swollen and collapsed states. 46 In this experiment a glucose gradient was set up from the donor to the receptor cell, and donor and receptor cell pH's were set initially at 7.0 and 4.6, respectively. Thus the membrane was initially in the collapsed state. We then measured glucose and proton diffusion by following glucose accumulation and pH decay, respectively, in the receptor chamber, with pH-stat in the donor chamber but not the receptor. It was found that glucose permeability increased suddenly from P gL ϭ6.2ϫ10 Ϫ6 cm/s to P gH ϭ7.3ϫ10 Ϫ5 cm/s when receptor pH increased past 5.2 and entered the swollen state. The proton decay rate changed less than 10% between the two states, and an apparent average value P p ϭ11ϫ10 Ϫ4 cm/s was calculated.
Due to the uncertainty as to the exact position of the transition points, it is difficult to use Eq. ͑3͒ to make precise predictions regarding the range of donor concentrations which should support oscillations. However, the transition points bracket pH 5, and Eq. ͑3͒ predicts that one should search in the vicinity of 1 mM glucose in the donor chamber. We have performed numerous runs in this range, and the curves in Figs. 5 and 6 typify the results. These figures demonstrate for the first time the capability of an enzyme/gel system, fed by a physiologically abundant substrate, glucose, to execute a series of autonomous on/off switches, accompanied by down/up pH swings. This system, then, shows promise as a prototype for a repetitively pulsing drug delivery device. However, the system does not oscillate indefinitely as desired, and it is necessary that we understand the damping of pH oscillations.
To begin the diagnosis procedure, we examine the validity of the five model assumptions with respect to our experiments. Assumption ͑1͒ is valid due to the vigorous stirring of the receptor chamber. Assumption ͑2͒ is valid as a result of ͑a͒ the relatively fast replenishment of glucose to the donor chamber; it is readily calculated that glucose is replenished much faster than it can flow by diffusion through the membrane, and ͑b͒ the donor compartment is well stirred, with proton concentration two orders of magnitude lower than the receptor chamber (pH 7 versus pHϳ5). Assumption ͑3͒ is valid due to the very high enzyme levels which cause glucose molecules to be consumed within several minutes, which is rapid compared to the timescale over which pH changes occur ͑Figs. 5 and 6͒. The validity of assumptions ͑4͒ and ͑5͒ is questionable, however, as will be discussed below.
The attenuation of oscillations cannot be attributed to an inactivation of the enzyme 47 or to an inefficient transfer of oxygen ͑cosubstrate͒ to the glucose oxidase, 48 because up and down swings in pH can be restored either by changing donor cell glucose concentration ͑Fig. 5͒, or by suddenly changing receptor cell pH by spiking with acid ͑Fig. 6͒. ͓We have also verified that in our well stirred experimental configuration, oxygen transfer from the atmosphere is such that O 2 concentration does not change during the experiment ͑data not shown͒.͔ Similarly, ''aging'' or ''fatigue'' of the membrane are ruled out by the responses to rechallenge seen in Figs. 5 and 6. We believe there are three possible factors which may explain the damped oscillatory behavior. The first factor is the possible buildup of gluconate ion with time in receptor chamber. The presence and dynamics of this species is ignored in the simple model. Although its pKa is low ͑3.7͒ and it will be mostly dissociated at the pH values of experimental interest ͑Ͼ4.7͒, significant buildup of gluconate could lead to buffering of the hydrogen ions produced by the enzyme reaction, which would tend to slow down and attenuate pH fluctuations. While gluconate is approximately the same size as glucose, it is negatively charged and may be Donnan excluded from the negatively charged membrane, 49 thus slowing its efflux from the receptor compartment and causing buildup there. The strength of Donnan exclusion is not certain, however, since the charge on the gel is not high and the solution ionic strength is significant. This issue will be resolved in the future by permeability studies of gluconate through the membrane, or by direct assay of gluconic acid concentration in the receptor chamber as a function of time. It is also possible that the gluconate buildup in the receptor chamber can be stalled, at least for awhile, by introducing anion exchangers into that chamber.
The second possible factor causing damping is the increased absorption and redistribution with time of protons by the pendant carboxylate groups in the gel membrane. By assumption ͑4͒, this absorption is ignored in the model, even though binding and unbinding of protons to the gel cause it to collapse and reswell. Reversible binding will buffer pH changes in the receptor to a degree that depends on the number of carboxylate groups in the membrane which are participating. It can be shown that the membrane's total proton binding capacity is quite large. However, the transmembrane pH gradient is such that most binding must occur on the side of the gel that is proximal to the receptor chamber where pH is low ͑ϳ5͒ compared to the other side where pH is high ͑7.0͒. Notice that this observation also implies that changes in glucose permeability are mediated by a skin layer next to the receptor chamber. We are presently uncertain about the thickness of the proton-binding layer, but note that the layer may grow thicker with time with ongoing exposure to newly generated protons, causing changes in permeability constants.
A related problem with assumption ͑4͒ is that the proton permeability is taken to be a lumped quantity, with the tacit consequence that proton flux is constant throughout the membrane at any given time. If reversible binding of protons to the membrane is occurring, however, then the time to establish a quasi-steady-state proton gradient in the membrane can be very large. 50, 51 It then behooves us to use a distributed model for proton transport. The apparent value of P h reported above is based on the rate of protons leaving the receptor compartment. Other experiments in our laboratory have shown, however, that this proton flux into the membrane is considerably larger than proton efflux on the donor side ͑data not shown͒. The latter observation is consistent with the notion of a growing degree of proton absorption into the membrane with time, which may alter the membrane's response characteristics.
The third factor which might explain the convergence of pH oscillations to an apparent steady state relates to the dynamics of the gel's response to proton concentration. According to assumption ͑5͒ the gel membrane will make its transition between glucose permeability states immediately upon passing the threshold values h HL or h LH . Indeed, glucose fluxes change drastically when pH is stepped across thresholds, as discussed previously. Further, assumption ͑5͒ states that permeabilities on either branch of the characteristic ͓Fig. 2͑a͔͒ are essentially constant. How closely does this assumption reflect the real behavior of the gel?
The most detailed studies of gel swelling equilibria and dynamics for gels undergoing discrete changes in swelling ͑i.e., first order phase transitions͒ have been performed on neutral gels, with temperature as the external controlling parameter. Two features stand out: First, there can be pronounced hysteresis in gel swelling; this is analogous to our permeation results. However, the swelling characteristic, with two stable branches ͑plus an unstable branch which is not of interest here͒, does not consist of two straight horizontal lines as has been suggested by assumption ͑5͒ and Fig. 2 . Rather, the characteristic tends to be rounded near the transition points. This is illustrated in Fig. 7 . Second, the time constants of swelling and deswelling as one approaches or crosses a transition temperature can depend drastically on the ''step size'' taken across that point. While the gel responds rapidly to large temperature steps, response to small steps which bring the temperature just below or just above the transition point can be exceptionally slow. 52 This is a manifestation in gels of the more general critical slowing down phenomenon associated with phase transitions. 53 The physical basis for this phenomenon in gels 52, [54] [55] [56] is beyond the scope of this presentation.
In the present system pH in the receptor chamber, not temperature, is the controlling variable, and there is a substantial transmembrane pH gradient. Also, permeability to glucose is probably modulated by a surface skin layer proximal to the receptor, as discussed above. Despite these differences, we conjecture that the true glucose permeabilityproton concentration characteristic will be rounded near the transition points, and that critical slowing may occur at those points.
The relevance of this discussion of gel transition equilibria and dynamics to our situation is made apparent by noticing that during the oscillation experiment ͑Figs. 5 and 6͒ a long time was required for pH to increase when the membrane was in the collapsed state ͑almost 24 h to go from pH 4.67 to 5.08 in Fig. 5 and from pH 4.87 to 5.06 in Fig.  6͒ . Apparently the residual diffusion of glucose through the collapsed gel and subsequent enzymatic production of H ϩ retards the increase of pH. As the slow change in pH traces the glucose permeabilty characteristic and enters the rounded region, intermediate permeabilities to glucose will be seen, which are not considered in the simple model of Eqs. ͑2͒. We conjecture that in such an intermediate permeability state, glucose permeation is just sufficient to produce enough protons to maintain the gel at that state, giving rise to the stationary conditions we have observed in our experiments. In support of this conjecture we note that the steady state pH's attained in Figs. 5 and 6 lie inside the hysteresis band ( pH ϳ4.7-5.2) inferred from the pH-stepping experiments. 41, 46 We speculate that the intermediate glucose permeability states are not detected in the stepping experiments, because the step sizes were large enough to avoid the rounded regions of the permeability characteristic. We also believe that the jumps were large enough to avoid the critical slowing region.
The slow pH dynamics seen in our experiments are due in great part to the large volume ͑75 ml͒ of the receptor chamber fluid. Therefore the pH rise and fall times can be reduced be using a smaller chamber, as suggested by Eqs. ͑4͒ or by simple surface to volume ratio considerations. We hypothesize that if pH is allowed to change rapidly enough, then the intermediate permeability states can be avoided, and oscillations will be restored. This hypothesis is based on the notion that critical slowing occurs precisely in the region where the permeability characteristic is rounded. Thus a rapid pass of pH through this region might provoke little change in permeability, but as pH passes the transition value and leaves the region of critical slowing, the membrane will shift rapidly to the other branch of its glucose permeability characteristic. A pictorial representation of the differences between the stepped pH, slow pH change, and rapid pH change scenarios is provided in Fig. 7 .
Before concluding, we make contact with related systems that have appeared in the literature. We first note that our proposed device is a hybrid of systems originally proposed by Hahn et al. 57 and by Katchalsky and Spangler. 58 Hahn et al. were interested in the general problem of reactions in a membrane bound system with constant reactant activity outside the cell, and where reactant and product permeabilities of the membrane depend on concentrations within the cell. Only monotonic, nonhysteretic permeability characteristics were considered, and it can be deduced from that work that such a system with the fast enzyme kinetics assumed in the present work will not produce sustained oscillations. Katchalsky and Spangler considered membrane hysteresis along with enzymatic reactions in the cell and discussed conditions for sustained oscillations in membrane permeability, but substrates were assumed to be provided from within the cell, and not from the external environment. Thus the system described in this paper combines aspects of the earlier efforts, and identifies hydrophobic polyelectrolyte gels as membranes that possess the needed properties. 40 includes a pH-sensitive gel, very similar in composition to the one we are using, in conjunction with a pH oscillator. In this system the gel's oscillations are slaved to the pH oscillations. In the second system, 59 NIPA is conjugated with a comonomer containing ruthenium ͑Ru͒, which serves as a catalyst for the BelousovZhabotinskii reaction. During the reaction the Ru switches between its reduced ͑II͒ and oxidized ͑III͒ states, hence altering the charge on the gel and the latter's swelling. In this case, the gel is a more active participant in the oscillation mechanism.
The systems of Yoshida et al., while interesting in their own right, are unlikely candidates for future use as drug delivery systems, due to the need to supply fresh reactants and remove products, and some of the chemicals may by toxic. Our system also differs from theirs in that its mechanism of oscillation relies on a hysteretic behavior of the gel, coupled with transport of glucose and the enzymatic conversion of glucose to acidic protons.
The present work also shares points in common with and points of divergence from other studies of glucose responsive constructs that are meant to emulate the pancreas. A number of research groups have incorporated glucose oxidase into weak polyelectrolyte, insulin containing hydrogels in order to cause the gels to alter the swelling in response to changes in external glucose levels. 4, 5, 60 Two strategies have evolved. In one approach the gel includes weak basic ͑ter-tiary amine͒ moities which causes the gel to swell ͑instead of collapse͒ as local pH drops in response to increased glucose levels. 4, 5 This swelling opens channels for insulin diffusion, leading to an increase in release. The second strategy is to incorporate weak acid ͑carboxylate͒ groups into the gel. 60 In this case a rise in glucose prompts the hydrogel to contract and squeeze out insulin by convection. In both cases it is presumed that the released insulin will cause blood glucose levels to fall, after which the gel will return to its quiescent state. Both strategies require that the gel retain its permeability to glucose even though permeability to insulin changes significantly; this requirement is readily fulfilled by using membranes that are hydrophilic even when not ionized.
The systems discussed in the previous paragraph respond to changes in external glucose level, while our system is intended to pulsate autonomously in the presence of constant external glucose activity. In order to be glucose responsive, the hydrogels studied by the other authors must retain their permeability to glucose at all times. Therefore these authors used gels containing reasonably hydrophilic uncharged comonomers ͑hydroxyethyl methacrylate 4, 5 or polyethylene glycol 60 ͒, and these gels have a relatively high water content at all times. Using the hydrophobic NIPA monomer in our system, we can shut down glucose transport through the gel to the enzymes. Also, the NIPA/MMA system exhibits first order transitions with permeability hysteresis, a feature absent from the more hydrophilic, glucose responsive systems. The resulting negative feedback with hysteresis is the basis for the desired pulsatile oscillations which occur in the presence of constant external glucose concentration.
V. CONCLUSIONS
In this paper we have identified a number of disorders that are best treated by the pulsed, oscillatory delivery of therapeutic agents, and have proposed a scheme to provide such delivery based on unstable feedback between a polyelectrolyte gel and an enzyme reaction system. A simple illustrative model was proposed, which identified conditions under which repetitive pulsations should occur, and experiments with a prototype system were carried out. These experiments demonstrated pulsations, but they were not repetitive. We have identified several possible explanations for the failure of the model system to produce the desired behavior, and suggested further experiments and more refined modeling.
The multiphasic swings in pH seen in this prototype system provide initial evidence that a gel/enzyme system, fed by an abundantly available, well controlled ͑in nondiabetics͒ endogenous substance such as glucose, can oscillate in its solute permeability properties. Such oscillations might someday be harnessed to provide periodic, pulsatile delivery of various therapeutic agents.
